Martingale Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
+69,280
| New | +$1.49M | 0.04% | 373 |
|
|
2023
Q3 | – | Sell |
-10,368
| Closed | -$248K | – | 777 |
|
|
2023
Q2 | $248K | Sell |
10,368
-4
| -0% | -$96 | ﹤0.01% | 730 |
|
|
2023
Q1 | $195K | Sell |
10,372
-2
| -0% | -$38 | ﹤0.01% | 783 |
|
|
2022
Q4 | $165K | Buy |
+10,374
| New | +$165K | ﹤0.01% | 802 |
|
|
2016
Q4 | – | Sell |
-6,900
| Closed | -$220K | – | 955 |
|
|
2016
Q3 | $220K | Sell |
6,900
-10,644
| -61% | -$339K | ﹤0.01% | 916 |
|
|
2016
Q2 | $570K | Sell |
17,544
-808
| -4% | -$26.3K | 0.01% | 647 |
|
|
2016
Q1 | $514K | Buy |
+18,352
| New | +$514K | 0.01% | 646 |
|
|
2013
Q4 | – | Sell |
-7,500
| Closed | -$207K | – | 980 |
|
|
2013
Q3 | $207K | Buy |
+7,500
| New | +$207K | 0.01% | 951 |
|